Lifestyle Factors Influencing Treatment Plans
Brad Glick, DO, MPH, says it is essential to consider patient lifestyles when choosing atopic dermatitis therapies.
Engaging in Shared Decision-Making
Brad Glick, DO, MPH, emphasizes the importance of personalized and inclusive communication in choosing therapeutics for atopic dermatitis.
Key Takeaways for the Management of Plaque Psoriasis
Experts in dermatology share final thoughts on the treatment of plaque psoriasis and the ever-changing treatment landscape.
Role of Diversity in Plaque Psoriasis Clinical Trials
Benjamin Lockshin, MD, FAAD, highlights diversity in clinical trials as an unmet need in approaching the treatment of plaque psoriasis.
Plaque Psoriasis Treatment Guidelines
Expert dermatologists discuss the treatment guidelines for plaque psoriasis, and how the decision about treatment is ultimately in the hands of the clinician.
Psychological Impact of Plaque Psoriasis
Nicholas Brownstone, MD, and James Q. Del Rosso, DO, comment on the psychological impact of plaque psoriasis on a patient’s quality of life.
Patient Case #3: 32-Year-Old Male With AD
Expert dermatologists review a final case about a 32-year-old male with AD, highlighting systemic therapy as first-line treatment.
Counseling AD Patients on Injection Concerns
Elizabeth Swanson, MD, shares pearls on how to communicate with AD patients who are uncertain about treatment through self-administered injection.
Patient Case #3: 48-Year-Old Male With Plaque Psoriasis
Experts in dermatology review a patient case of a 48-year-old man with plaque psoriasis who is having trouble with topical therapy.
Patient Case #2: 60-Year-Old Female With Chronic Intertrigo
Dermatology experts discuss a patient case concerning a 60-year-old woman with chronic intertriginous psoriasis who is taking a biologic drug for inflammatory bowel disease.
Guidelines and Recommendations for Therapies in AD
Experts in dermatology review recommendations for systemic therapies and JAK inhibitors in the management of AD and other factors that guide treatment selection.
Patient Case #2: Adolescent Male With AD
Jonathan I Silverberg, MD, PhD, MPH; Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, discuss their initial impressions of an adolescent patient with AD, focusing on systemic therapy.
Patient Case #1: 29-Year-Old Female With Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, and Benjamin Lockshin, MD, FAAD, review a case of a female patient with a family history of plaque psoriasis.
Mechanism of Action of Tapinarof in Plaque Psoriasis
Experts discuss the unique mechanism of action of tapinarof and its use in the treatment of plaque psoriasis.
Patient Case #1: AD Treatment Options
Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, highlight treatment options for a specific patient with AD, focusing on dupilumab.
Treatment of AD in Clinical Practice
Experts in dermatology review clinical trials for AD treatment and how this data translates into their own practices.
Efficacy of Tapinarof in Plaque Psoriasis
James Q. Del Rosso, DO, and Dawn L. Sammons, DO, FAOCD, FAAD, review the efficacy of a new topical agent in the treatment of plaque psoriasis, tapinarof, highlighting the remittive data.
Treatment Selection in Plaque Psoriasis
Experts in dermatology discuss newer topical treatments, such as tapinarof, in the management of plaque psoriasis.
Use of Dupilumab in AD
Expert dermatologists review the use of dupilumab for the treatment of AD, focusing on the once-monthly shot as a factor in selection.
Patient Case #1: AD Treatment Approaches
Elizabeth Swanson, MD, and Brad Glick, DO, MPH, FAOCD, share treatment approaches for pediatric patients with AD.
Resident Training in Plaque Psoriasis
Nicholas Brownstone, MD, comments on how newer treatments in plaque psoriasis can impact residency training.
Topical vs Systemic Therapy in Plaque Psoriasis
Dawn L. Sammons, DO, FAOCD, FAAD, shares her approach to using topical vs systemic therapy in plaque psoriasis, focusing on patient preference as the driving factor for treatment selection.
Patient Case #1: 6-Year-Old Male Patient With Moderate AD
Expert dermatologists present and share initial impressions of a patient case for a 6-year-old male with AD, highlighting the impact of sleep deprivation.
Switching Treatment in AD
Jonathan I Silverberg, MD, PhD, MPH; Elizabeth Swanson, MD; Brad Glick, DO, MPH, FAOCD; and Andrew Blauvelt, MD, MBA, review factors that lead to switching therapies in AD, focusing on monotherapies vs combination therapy.
Use of Topical Treatment in Plaque Psoriasis
Brad Glick, DO, FAOCD, highlights topical therapy as a targeted treatment of plaque psoriasis.
The Pathogenesis of Plaque Psoriasis
Benjamin Lockshin, MD, FAAD, comments on how the evolution of the pathophysiology of plaque psoriasis has led to more targeted therapies to treat the disease.
Time to Treatment Response in AD Treatment Selection
Experts in dermatology comment on how often quickness of response to therapy determines treatment selection for teenaged patients with AD.
Treatment Selection for AD
Expert dermatologists discuss treatment selection for short-term rescue vs long-term maintenance therapy.
Use of Systemic vs Topical Treatment of AD
Andrew Blauvelt, MD, MBA, reviews systemic vs topical treatment of AD, discussion patient preferences as a factor for treatment selection.
Treatment Landscape for Atopic Dermatitis (AD)
Experts in dermatology discuss the rapidly expanding treatment landscape of atopic dermatitis and how these new treatment options have changed the management of AD.
